Table 1 Demographic and clinicopathological characteristics of patients with ENB
From: A novel nomogram to predict the overall survival in esthesinoeroblastoma
Characteristics | Training cohort (N = 225) (%) | Validation cohort (N = 87) (%) | P value |
|---|---|---|---|
Gender (%) | 0.136 | ||
Female | 92 (40.9) | 29 (33.3) | |
Male | 133 (59.1) | 58 (66.7) | |
Age (%) | 0.034 | ||
< =54 | 122 (54.2) | 61 (70.1) | |
55–69 | 73 (32.4) | 20 (23.0) | |
> =70 | 30 (13.3) | 6 (6.9) | |
Tumor Grade (%) | 0.304 | ||
Low | 129 (57.3) | 56 (64.4) | |
High | 96 (42.7) | 31 (35.6) | |
Modified Kadish(%) | 0.002 | ||
A | 49 (21.8) | 1 (1.1) | |
B | 13 (5.8) | 26(29.9) | |
C | 137 (60.9) | 37 (42.5) | |
D | 26 (11.6) | 23 (26.4) | |
Chemotherapy(%) | 0.005 | ||
N | 146 (64.9) | 42 (48.3) | |
Y | 79 (35.1) | 45 (51.7) | |
Radiotherapy(%) | 0.461 | ||
N | 72 (32.0) | 29 (33.3) | |
Y | 153 (68.0) | 58 (66.7) | |
Surgery(%) | < 0.001 | ||
N | 22 (9.8) | 51 (58.6) | |
Y | 203 (90.2) | 36 (41.4) | |